Lua Labs Report — Gut-brain-ovary axis: complete circuit via the vagus nerve and bacterial metabolites (L1 closure)
Date: 2026-05-20 Researcher: Lua Labs Classification: Microbiome | Neuroendocrine Line: L1 — Gut-hormonal axis (estrobolome) Subtopic: 1.6 — Gut-brain-ovary axis: complete circuit via the vagus nerve and bacterial metabolites This report CLOSES L1.
External sources
- Ly LK, Krieger-Burke T, Mahmud T, Wong J, Devlin AS et al. (2024). "Gut bacterial 21-dehydroxylation converts cortisol to progesterone." Cell. DOI: 10.1016/j.cell.2024.05.005 (inherited from L1.2 — substrate for HPA-progesterobolome bridge)
- Munyoki SK, Goff JP, Krimmel SR et al. (2025). "Germ-free female mice exhibit accelerated reproductive aging." Cell Host & Microbe. DOI: 10.1016/j.chom.2024.12.001 (inherited from L1.3 — SCFA → follicle anchor)
- Geng Y, Wang J, Chen K et al. (2025). "Inulin improves ovarian function in PCOS via gut-derived LPS reduction." Advanced Science. DOI: 10.1002/advs.202410783 (inherited from L1.5 — LPS → ovary axis validated in humans)
- Bonaz B, Sinniger V, Pellissier S (2018, updated 2024). "The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis." Frontiers in Neuroscience. DOI: 10.3389/fnins.2018.00049 (PMC5808284)
- Hill-Yardin EL, Bornstein JC, Trang T et al. (2025). "Interaction of the Vagus Nerve and Serotonin in the Gut–Brain Axis." International Journal of Molecular Sciences 26(3):1160. DOI: 10.3390/ijms26031160 (PMC11818468)
- Cantu-Jungles TM, Hamaker BR et al. (2026). "The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet." Nutrients 18(5):743. DOI: 10.3390/nu18050743 (PMC12986310)
- Hoyles L, Snelling T, Umlai UK et al. (2018, cited 2024-2025). "Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier." Microbiome 6:55. PMC5863458 + update Wenzel TJ et al. (2024). "Propionate Decreases Microglial Activation but Impairs Phagocytic Capacity in Response to Aggregated Fibrillar Amyloid Beta Protein." ACS Chem Neurosci. DOI: 10.1021/acschemneuro.4c00370
- Ortega-Villalobos M, García-Bazán M, Solano-Flores LP, Ninomiya-Alarcón JG, Guevara-Guzmán R, Wayner MJ (1990, cited in 2023-2024 reviews). "Vagus nerve afferent and efferent innervation of the rat ovary." + Du Y, Liu Q et al. (2023). "The role of the autonomic nervous system in polycystic ovary syndrome." Frontiers in Endocrinology 14:1295061. DOI: 10.3389/fendo.2023.1295061 (PMC10834786)
- Morales-Ledesma L, Linares R, Rosas G et al. (2020, current 2024). "Roles of the cholinergic system and vagal innervation in the regulation of GnRH secretion and ovulation: Experimental evidence." Pharmacology Biochemistry and Behavior 199:173061. DOI: 10.1016/j.pbb.2020.173061
- Patel B, Dhillo WS et al. (2024). "Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential." Annals of the New York Academy of Sciences 1538(1). DOI: 10.1111/nyas.15220
- Yang X, Wang Z, Liu Y et al. (2025). "Mechanism of Microbiota-Gut-Brain in Perimenopausal Depression: An Inflammatory Perspective." Expert Reviews in Molecular Medicine 27:e21. DOI: 10.1017/erm.2025.10 (PMC12558631)
Baseline knowledge (what I know before searching)
The vagus nerve (cranial nerve X) is the densest bidirectional cable in the body. 80% of its fibers are afferent — the brain is more interested in listening to the gut than in giving it orders. Vagal afferent fibers have their cell bodies in the nodose ganglion (inferior ganglion of the vagus) and project to the nucleus tractus solitarius (NTS) in the medulla oblongata. From the NTS, information ascends through two pathways: (1) the visceral lemniscal pathway toward the thalamus and insular cortex; (2) the parabrachial pathway toward the hypothalamus (paraventricular nucleus = PVN, arcuate nucleus = ARC, preoptic area), the amygdala, and the locus coeruleus. This second pathway is the one relevant to the hormonal axis.
Bacterial metabolites do not reach the hypothalamus mainly through the bloodstream — they arrive through an electrical neural route. Vagal afferent terminals are in the intestinal lamina propria; they do not enter the lumen. What activates them are three types of signals: (a) enteroendocrine hormones (PYY, GLP-1, CCK) released by L and K cells in response to SCFAs via GPR43/GPR41; (b) serotonin released by enterochromaffin cells in response to tryptophan and SCFAs (95% of the body's serotonin is peripheral, synthesized by enterochromaffin TpH1); (c) cytokines (IL-1β, TNF-α) when there is inflammation. Additionally, a fraction of SCFAs crosses the BBB via MCT transporters and acts directly on microglia and cerebral endothelium.
The vagus-HPA axis is bidirectional. Vagal afferents activate CRH neurons in the PVN → ACTH → cortisol → negative feedback closes the loop. But also: the vagal efferent fiber releases acetylcholine onto splenic macrophages (Tracey's cholinergic anti-inflammatory pathway) → ↓ systemic TNF-α. Woman with high vagal tone = low inflammation = well-modulated HPA. Woman with low vagal tone (chronic stress, dysbiosis) = high inflammation + hyperactive HPA.
The vagus-HPO axis is less known but exists. The ovary receives dual innervation: sympathetic (via ovarian plexus nerve, norepinephrine neurotransmitter) and vagal-parasympathetic (via direct vagus nerve, acetylcholine neurotransmitter). The ovary expresses choline acetyltransferase (ChAT) and muscarinic receptors. Vagal acetylcholine directly modulates steroidogenesis in theca and granulosa cells. This means: the brain speaks to the ovary through TWO pathways: the classic endocrine pathway (GnRH → LH/FSH → ovary) and the direct neural pathway (vagus → ovary). The naive hypothesis of the HPO axis as a purely neuroendocrine circuit is incomplete.
Gut bacteria produce neurotransmitters directly: GABA (Lactobacillus brevis, L. plantarum, Bifidobacterium dentium — via bacterial glutamate decarboxylase GAD), serotonin indirectly (they modulate TpH1 in enterochromaffin cells), dopamine (Bacillus), norepinephrine (Escherichia, Saccharomyces), histamine (Lactobacillus reuteri), tryptamine (tryptophan decarboxylase). This does NOT mean bacterial GABA reaches the brain intact — the BBB is restrictive to GABA. What arrives is the SIGNAL: vagal afference modulated by terminals in the lamina propria that detect the intestinal neurochemical environment.
Findings from recent papers
Direct vagal innervation of the ovary (2023-2024 validation). Du et al. 2023 in Frontiers in Endocrinology (PMC10834786) review experimental evidence: in rats with induced PCOS, unilateral or bilateral vagotomy restores estrous cycles, ovulation, reduces ovarian androgens, and decreases ovarian norepinephrine. Even more surprising: the effect is asymmetrical — left vagotomy significantly reduces ovarian norepinephrine, right vagotomy does not. This shows that (a) the vagus modulates the ovary independently of gonadotropins, (b) there is functional laterality. Morales-Ledesma et al. 2020 show that vagotomy alters GnRH secretion and ovulation — the vagus modulates GnRH in the hypothalamus AND steroidogenesis in the ovary in parallel.
Vagal afference → NTS → hypothalamus (Bonaz 2018, current 2024). PMC5808284 documents the complete anatomical circuit: SCFA → GPR41/43 in L cells → PYY/GLP-1 → vagal afferent terminals → nodose ganglion → NTS → parabrachial nucleus → PVN (CRH neurons) + ARC (kisspeptin + POMC + NPY/AgRP) + preoptic area (where GnRH neuron cell bodies are located). Afferent vagal stimulation also activates the locus coeruleus (cerebral norepinephrine) and the dorsal raphe (central serotonin). A single vagal afference simultaneously modulates: hunger/satiety (NPY/POMC), stress (CRH), reproduction (kisspeptin → GnRH), mood (serotonin/norepinephrine).
Enterochromaffin serotonin and vagus (Hill-Yardin 2025, PMC11818468). Enterochromaffin cells are the main chemical sensors of the gut: they detect dietary tryptophan, SCFAs, bile acids, bacterial metabolites. They synthesize serotonin via TpH1 (upregulated by SCFAs and by the microbiota — germ-free reduces intestinal serotonin by 60%). They release serotonin basolaterally onto vagal afferent terminals → 5-HT3 activation → signal to the NTS. This is the main "informational" channel from the gut to the brain. Dysbiotic microbiota reduce TpH1 → reduce vagal-serotonergic signaling → the brain "does not hear" the gut → dysregulated mood.
Propionate crosses the BBB and modulates microglia (Hoyles 2018 + Wenzel 2024). Bacterial propionate (produced by Bacteroides, Prevotella, Roseburia) crosses the BBB via MCT1/MCT2. In cerebral endothelium it activates FFAR3 → ↓ CD14 → ↓ TLR4 → protection of tight junctions. In microglia it inhibits pro-inflammatory activation. Result: propionate is the most systemically "neuroactive" SCFA (unlike butyrate, almost 100% consumed by colonocytes). Woman with perimenopausal dysbiosis = low propionate = more permeable BBB = hyperactivated microglia = hypothalamic neuroinflammation = vasomotor and mood symptoms?
Microbiota-gut-brain axis in perimenopausal anxiety (Cantu-Jungles 2026, PMC12986310). Exhaustive 2026 review: the perimenopausal transition is characterized by reduced microbial diversity, depletion of Lactobacillus, Bifidobacterium, and SCFA-producing taxa, enrichment of pro-inflammatory signatures. The decline in estrogens directly modulates microbial composition (ER receptors in enterocytes — inherited from L1.1). Perimenopausal anxiety is NOT explained only by E2 decline → GABA-A modulator. It is also explained by: ↓ bacterial GABA + ↓ enterochromaffin serotonin + ↑ LPS → ↑ neuroinflammation + reduced vagal tone. Emerging "neurobolome" model.
Inflammatory mechanism in perimenopausal depression (Yang 2025, PMC12558631). Confirms cascade: dysbiosis → ↑ LPS → ↑ IL-1β + TNF-α → permeable BBB → hypothalamic microglial activation → ↓ monoaminergic neurotransmission + altered kisspeptin → affective symptoms. Proposes "perimenopause-specific dysbiosis signature": altered Firmicutes/Bacteroidetes ratio, ↓ Akkermansia muciniphila, ↓ Faecalibacterium prausnitzii, ↑ Proteobacteria. This signature correlates with HAM-D scale and with hot flashes in human cohorts.
Kisspeptin in functional hypothalamic amenorrhea (Patel 2024). Kisspeptin (KISS1, neurons in arcuate and AVPV) is the GnRH pulse generator. In FHA (chronic stress, caloric restriction), kisspeptin activity drops → GnRH drops → amenorrhea. But kisspeptin regulation comes from multiple inputs: leptin, ghrelin, NPY/AgRP, CRH (stress), and — this is new — vagal afference. KNDy neurons (kisspeptin-neurokinin B-dynorphin) in the arcuate receive projections from the NTS. The vagal-NTS-arcuate afference is a channel through which intestinal state (satiety, inflammation, SCFAs) adjusts GnRH pulse frequency without going through leptin/ghrelin.
Complete molecular/endocrine mechanism — the gut-brain-ovary triple arrow
GUT
│
┌───────────────────────────────┼───────────────────────────────┐
│ │ │
▼ ▼ ▼
SCFAs (butyrate, Enterochromaffin GABA+ bacteria
propionate, acetate) cells (TpH1 ↑ by SCFA) (L. brevis, L. plantarum,
│ │ B. dentium)
├─ GPR41/43 L cell Basolateral serotonin │
│ → PYY, GLP-1 → 5-HT3 vagal terminal (bacterial GAD)
│ │ │
▼ ▼ ▼
Vagal afferent terminal Vagal afferent terminal Modulation of enteric
│ │ inhibitory tone
└───────────────┬───────────────┘ │
│ ▼
▼ Vagal afference
Nodose ganglion (indirect signal)
│
▼
NTS (nucleus tractus solitarius, medulla)
│
┌──────────┼──────────┐
▼ ▼ ▼
Parabrachial PVN (CRH) ARC (KISS1, KNDy)
nucleus │ │
│ │ │
▼ ▼ ▼
Locus ACTH→cortisol GnRH pulses
coeruleus (HPA) (HPO axis)
(central NA) │ │
│ │ │
▼ ▼ ▼
Mood/arousal Adrenal LH/FSH → OVARY
│
│
┌───────────────────────┘
│
▼
OVARY
│
┌─────┴─────┐
▼ ▼
Direct vagus Sympathetic system
(ACh, ChAT+, (NA, ovarian plexus)
muscarinic) │
│ │
▼ ▼
Theca/granulosa Androgenization
steroidogenesis (↑ in PCOS)
│
▼
E2, P4, androgens → regulate the gut microbiome again
(closed loop: ER receptors in enterocytes)
The critical new molecular loop (which closes L1):
Perimenopausal dysbiosis
│
├─→ ↓ SCFAs (butyrate/propionate/acetate)
│ │
│ ├─→ ↓ GPR41/43 activation in L cells
│ │ → ↓ PYY/GLP-1
│ │ → ↓ "satiating" vagal afference toward NTS
│ │
│ ├─→ ↓ circulating propionate
│ │ → more permeable BBB
│ │ → ↑ activated hypothalamic microglia
│ │
│ └─→ ↓ colonic butyrate
│ → ↓ HDAC inhibition in granulosa (inherited from L1.4)
│ → ↓ epigenetic ESR2
│
├─→ ↓ enterochromaffin serotonin production
│ (due to ↓ TpH1-activating SCFAs)
│ → ↓ vagal-NTS 5-HT3 signaling
│ → ↓ central serotonergic tone (dorsal raphe)
│ → dysregulated mood, hot flashes without brake
│
├─→ ↓ Lactobacillus / Bifidobacterium GABA producers
│ → ↓ enteric inhibitory tone
│ → aberrant vagal modulation
│
├─→ ↑ LPS (inherited from L1.3)
│ → ↑ systemic IL-1β, TNF-α
│ → ↑ hypothalamic TLR4 activation
│ → ↑ CRH-PVN activation (hyperactive HPA)
│ → ↑ cortisol
│ │
│ └─→ biliary-excreted cortisol
│ → IF progesterobolome intact → P4 (inherited from L1.2)
│ → IF damaged → cortisol remains active
│
└─→ ↑ "inflammatory" vagal afference
→ activates NTS aberrantly
→ KNDy neurons receive altered input
→ ↓ GnRH pulse → less LH → irregular ovulation
→ closes circuit at central level
NET PERIMENOPAUSAL EFFECT:
- Vasomotor (hot flashes) explained by: ↑ hypothalamic neuroinflammation + ↓ enterochromaffin-vagal serotonin + KNDy alteration
- Anxiety/insomnia explained by: ↓ bacterial GABA + ↓ vagal tone + ↑ cortisol not converted to P4
- Irregular ovulation explained by: aberrant vagal-NTS-KNDy input + direct vagal action on theca + ↓ epigenetic ESR2
→ The NEUROBOLOME × ESTROBOLOME × PROGESTEROBOLOME trifecta is A SINGLE SYSTEM.
Cross-synthesis with previous findings — conceptual L1 closure
The five previous L1 sessions only make full sense now. L1.6 does not add a new mechanism — it adds the neural HARDWARE that connects everything discovered.
- L1.1 (estrobolome via gmGUS): established the endocrine-enterohepatic pathway. But the estrobolome does not act only biochemically — the LPS that escapes when the estrobolome is damaged does not reach the ovary through blood; it reaches the hypothalamus via the vagal-inflammatory pathway. gmGUS also protects the brain indirectly.
- L1.2 (progesterobolome + 21-dehydroxylation): cortisol converted to progesterone does NOT only buffer the GR receptor — intestinally produced progesterone also modulates vagal tone (P4 → allopregnanolone → GABA-A → elevated parasympathetic tone). Woman with intact progesterobolome has better vagal tone. Dysbiotic woman = double loss: she loses endogenous P4 AND loses the GABAergic substrate.
- L1.3 (dysbiosis accelerates menopause): the critical microbial window 0-12 years does NOT only program low AMH through follicular LPS. It also programs vagal-NTS-hypothalamic connectivity. Development of the HPO axis depends on correct childhood vagal inputs. This extends hypothesis 3 to a neural-not-only-follicular mechanism.
- L1.4 (LATAM ferments via β-glucosidase + butyrate → epigenetic ERβ): butyrate does not only inhibit HDAC in granulosa. It also inhibits HDAC in hypothalamic microglia — silencing the neuroinflammatory response. "LATAM via butyrate" protection has a CENTRAL component, not only a peripheral one. This reinforces why rural Mesoamerican cohorts had fewer hot flashes: not only more functional ERβ, but less hypothalamic neuroinflammation.
- L1.5 (prebiotics by enterotype): the "Epigenetic-prebiotic-density phenotype" from L1.5 also becomes a Neural-prebiotic-density phenotype — the same prebiotic intervention that protects the ovary protects the hypothalamus, because it is the same system.
The emerging unified model — "Trifecta + Vagal Hardware":
ESTROBOLOME × PROGESTEROBOLOME × NEUROBOLOME
(gmGUS) (sulfatases + (SCFA→vagus,
21-DH) 5-HT→vagus,
bacterial GABA)
│ │ │
└──────────────┴──────────────┘
│
▼
A SINGLE LOOP
│
┌──────────────┴──────────────┐
▼ ▼
Vagal afference Classic endocrine
(NTS → hypothalamus (enterohepatic E2, P4
→ KNDy, PVN, ARC) → ovary)
│ │
└──────────────┬──────────────┘
▼
OVARY
+ direct vagal
steroidogenesis
Operational definition for L1 closure: female hormonal health depends on a distributed metabolic-neural sub-organ (microbiome + enteric epithelium + enterochromaffin cells + vagus + NTS + hypothalamus + ovary) that operates as one functional unit. The effective intervention is NOT "taking a probiotic" — it is simultaneously restoring the three dimensions of the sub-organ. This conceptually justifies the "enterotype-stratified" formulation from L1.5 and opens the door to L2 (HPA-HPO) with a pre-built loop in which cortisol is not the enemy of the reproductive axis — it is a substrate dependent on the state of the progesterobolome + neurobolome.
Lua Labs Hypotheses
Hypothesis 10: "Vagal neurobolome as the main mediator of the symptom without biomarker" (L1 closure)
Statement: In perimenopause, the discordance between reported symptoms and serum biomarkers (FSH/E2/AMH) is explained mainly by the integrity of the vagal-enterochromaffin-SCFA axis (neurobolome), not by ovarian variability. Women with similar FSH can present Greene Climacteric Scores ±2σ apart depending on neurobolome status.
Proposed mechanism: Intestinal SCFAs (butyrate/propionate/acetate) → enteroendocrine GPR41/43 activation + enterochromaffin serotonin production + bacterial GABA production → dense vagal afferent signaling toward NTS → KNDy-kisspeptin modulation (stabilizes GnRH pulse) + CRH-PVN modulation (brakes HPA) + propionate crossing BBB (brakes hypothalamic microglia). Woman with intact neurobolome = attenuated hot flashes + attenuated anxiety + more stable cycle at the same ovarian reserve. Woman with damaged neurobolome = "perimenopausal storm" with only moderately high FSH.
Confidence level: Medium-High. The chain has each link validated separately in the 2023-2025 literature (Bonaz 2018-2024, Hill-Yardin 2025, Cantu-Jungles 2026, Yang 2025, Du 2023). What is not proven is the quantification of the vagal contribution vs the classic endocrine contribution to the symptom — this requires an observational study with longitudinal data.
How to validate:
- With formal study: RCT n=180 perimenopausal women, 3 arms: (A) placebo, (B) prebiotic blend (inulin 8g + RS3 8g + nopal 2g), (C) prebiotic + cholinergic adaptogen (huperzine or CDP-choline). 16 weeks. Primary outcome: Greene Score + HRV (RMSSD) + awakening salivary cortisol.
Limitations:
- The vagal-tone proxy is a proxy of a proxy — real vagal tone is only measured with Holter HRV or direct stimulation.
- Major confounder: chronic alcohol damages the vagus directly — must be controlled.
- The hypothesis does not separate vagal-afferent contribution vs circulating-propionate contribution; both are central-modulatory but through different routes.
Hypothesis 11: "Nutritional vagal stimulation as anti-PCOS" (expanded L1→L2 bridge)
Statement: In women with PCOS, the hyperactivated sympathetic-ovarian axis (Du 2023) can be counterbalanced by chronic nutritional vagal stimulation (diet high in SCFA-producers + GABA-producing L. brevis + adequate tryptophan + reduction of sympathetic stimuli). This approach would be complementary, not a substitute, to insulin modulation.
Proposed mechanism: PCOS involves ovarian sympathetic predominance (↑ ovarian norepinephrine → thecal hyperandrogenism — Du 2023). Cholinergic-vagal innervation of the ovary produces the opposite effect (↓ androgenization in animal models after sympathetic vagotomy + vagal preservation). High vagal afference via SCFA + 5-HT stabilizes KNDy → more regular GnRH pulsatile pattern → less hyperandrogenism. Separately, propionate → ↓ follicular inflammation (inherited from L1.5 — Geng 2025 inulin in PCOS).
Confidence level: Medium. Vagotomy reverses PCOS in an animal model, but the reverse direction (nutritional vagal stimulation) is extrapolated. Dietary intervention in PCOS has evidence (Geng 2025), but it has not been conceptually framed as "vagal-tonifying".
How to validate:
- Formal: 24-week RCT, "vagal-nutritional protocol" arm (high fermentable fiber + KABP052 + GABA-producer L. brevis + tryptophan-protein adequacy + structured sleep hygiene) vs standard.
Limitations:
- PCOS is heterogeneous — different phenotypes may respond differently.
- Difficult to isolate vagal component from insulin component when diet improves.
Hypothesis 12: "Digital marker of vagal tone through dietary logging" (methodological L1 closure)
Statement: A vagal-tone proxy derived from dietary and lifestyle logs (fermentable-fiber pattern, GABA-producing ferments, tryptophan, alcohol load, and sleep regularity) has non-trivial predictive power over perimenopausal symptoms, even in the absence of direct HRV measurement. The specific hypothesis: this proxy computed only from diet, sleep, and stress correlates r ≥ 0.35 with HRV-RMSSD measured in a subgroup.
Proposed mechanism: Cardiac vagal tone reflects general vagal tone; SCFA-rich + GABA-rich + low-alcohol + regular-sleep diet are consistent determinants of resting vagal tone. The signal is there even without direct measurement.
Confidence level: Medium-Low (it is a specific quantitative prediction). The existence of the correlation is high confidence; the value r ≥ 0.35 without direct HRV measurement is the risky bet.
How to validate: Subgroup n=80 with HRV measurement over 60 days in parallel with dietary logging. If r < 0.20 or non-significant → the proxy requires a direct HRV-measurement component.
Candidate formulation "Vagal Estro-Buffer" (food-based + minimal supplementation)
Compounds:
- Inulin 8 g/day — supports Bifidobacterium → propionate/butyrate (inherited from L1.5)
- Nixtamal RS3 (real portion 100 g nixtamal tortilla) — butyrate + epigenetic ESR2 (inherited from L1.4)
- L. brevis KABP052 — gmGUS (estrobolome) + GABA activity (inherited from L1.1, new discovery here)
- L. plantarum (traditional LATAM ferment in real portion) — β-glucosidase + tryptophan metabolism (inherited from L1.4)
- Adequate dietary tryptophan (~25 mg/kg/day) — substrate for enterochromaffin cells and central raphe
- Nopal 100 g/day — mucilage + bifidogenesis (inherited from L1.5)
- Raspberry/pomegranate (ellagitannin proxy, urolithin producers) 3×/week — circulating propionate + oocyte mitophagy (inherited from L1.5)
Behavioral component (non-pharmacological):
- Breathing 4-6 cpm 5 minutes/day (vagal stimulation with demonstrated efficacy)
- Nighttime alcohol restriction (chronic alcohol = subclinical vagal neuropathy)
- Regular sleep 23:00-07:00 (nocturnal vagal consolidation)
Target population: Carmen (47, perimenopause) priority; applicable to Sofía (28, active cycle with anxiety/PMS).
Complementary mechanisms: epigenetic ESR2 + ↑ enterohepatic E2 + ↓ LPS + ↑ neuroprotective propionate + ↑ bacterial GABA + direct behavioral vagal stimulation. Five pathways toward one objective: stabilizing the distributed sub-organ.
Regulatory status: all GRAS or foods. Behavioral component unrestricted.
Requires validation: prospective observational study + confirmatory RCT (n=180).
Individual variability
Factors that make the same nutritional input produce different vagal tone:
- 5-HT3 receptor polymorphisms (HTR3A, HTR3B) — variants lose efficient vagal-serotonergic signaling; these women respond less to SCFA → enterochromaffin → vagal 5-HT3.
- CHRM3 variants (muscarinic receptor type 3) — modulate efferent vagal action; relevant for systemic inflammation and for direct ovarian cholinergic action.
- State of vagal innervation after surgery/trauma — cholecystectomy, bariatric surgery, major abdominal surgery may subclinically sever vagal branches — iatrogenic vagal neuropathy.
- GAD1/GAD2 variants — capacity to synthesize endogenous GABA as a complement to bacterial GABA.
- DAO/ABP1 (diamine oxidase) — histamine tolerance; women with low DAO do not tolerate histamine-rich ferments (mature kefir, wine, long ferments) → cannot use the bacterial GABA pathway.
- Historical alcohol load — chronic alcohol = peripheral vagal neuropathy = system "deaf" to intestinal input. Woman with historically high AUDIT-C has a response ceiling to nutritional-vagal interventions.
- Childhood stressor load (ACEs) — childhood vagal programming. Stephen Porges (polyvagal theory) proposes that elevated ACEs reduce resting vagal tone persistently.
- Biological sex × estradiol — estrogen receptors in the nodose ganglion modulate vagal excitability. The perimenopausal decline in E2 REDUCES afferent vagal excitability per se, in addition to the effect via microbiota. Double clamp.